Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Tech

Webull Rockets 375% Following IPO as Retail Traders Pile In

Webull (NASDAQ: BULL) exploded onto Wall Street this week, rocketing 375% in just its second day of trading following a…

Read More »
Stocks

Wall Street Roars as Trump Tariff Pause Sparks Historic Market Rally​

In a stunning turn on Wednesday, Wall Street roared to life as markets posted historic gains following President Donald Trump’s…

Read More »
Stocks

Top Inverse ETFs to Capitalize on Trump’s Tariff Turmoil

In the wake of President Donald Trump’s revived tariff strategy, Wall Street is bracing for a storm. With sweeping new…

Read More »
Biotech

Quantum BioPharma Boasts Enhanced Financials, Clinical Successes, and New Alcohol Misuse Treatment

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is riding a wave of optimism following robust financial improvements, promising clinical…

Read More »
Biotech

Quantum BioPharma Expands unbuzzd™ Retail Push, Doubles Down on Bitcoin

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) isn’t standing still. The biopharmaceutical innovator behind the clinically validated…

Read More »
Tech

MicroAlgo Stock Soars 455%—What’s Driving MLGO’s Meteoric Rise?

Shares of MicroAlgo (NASDAQ: MLGO) experienced an epic breakout on Monday, soaring 455% in a single trading session to close…

Read More »
Tech

U Power Accelerates Southeast Asia EV Push With Game-Changing Thai Joint Venture

U Power Limited (NASDAQ: UCAR) just hit the accelerator on its Southeast Asia expansion. The EV battery-swapping innovator signed a…

Read More »
Economy

Fed Holds Rates Steady, Stocks and Crypto Surge

The Federal Reserve kept interest rates unchanged at its policy meeting on Wednesday, maintaining the federal funds rate in the…

Read More »
Biotech

Shuttle Pharma Bolsters Leadership, Secures $5.75M in New Funding

Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, has taken two…

Read More »
Stocks

Tariffs Turmoil: Weather the Storm With These Dividend Stocks

The financial landscape is currently dominated by escalating trade tensions, with President Trump’s recent tariff policies introducing significant uncertainty. Trump’s…

Read More »
Back to top button